Clinical Trial Update: Personalized SBRT in Early-Stage Peripheral NSCLC [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for personalized SBRT in early-stage peripheral non-small cell lung cancer, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Early-stage Peripheral Non-small Cell Lung Cancer | Phase 2 | Status: ENROLLING_BY_INVITATION